Shanghai Whittlong Pharmaceutical Institute
惠永药物
Shanghai Whittlong Pharmaceutical Institute
Biotech/Healthcare
Founded in Zhangjiang in May 2018, Huiyong Pharmaceutical is a mixed-ownership pilot company under Shanghai Pharmaceuticals focused on the R&D of advanced drug formulations. In just over two years, the company grew rapidly and established technology platforms for oral controlled- and…
Latest round: Pre Series B (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.